verteporfin |
|
CHEBI:32293 |
|
An equimolar mixture of the 9-methyl ester and 13-methyl ester of trans-(±)-18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]porphine-9,13-dipropanoic acid. It is used as a photosensitizer in photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with neovascular (wet) age-related macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when activated by red (693 nm) laser light in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
|
autophagy inhibitor
Any compound that inhibits the process of autophagy (the self-digestion of one or more components of a cell through the action of enzymes originating within the same cell).
|
|
photosensitizing agent
A chemical compound that can be excited by light of a specific wavelength and subsequently transfer energy to a chosen reactant. This is commonly molecular oxygen within a cancer tissue, which is converted to (highly rective) singlet state oxygen. This rapidly reacts with any nearby biomolecules, ultimately killing the cancer cells.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
Outgoing
|
verteporfin
(CHEBI:32293)
has part
(2R,21S)-8-ethenyl-21,22-bis(methoxycarbonyl)-17-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,21-dihydrobenzo[b]porphyrin-13-propanoic acid
(CHEBI:60775)
verteporfin
(CHEBI:32293)
has part
(2R,21S)8-ethenyl-21,22-bis(methoxycarbonyl)-13-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,21-dihydrobenzo[b]porphyrin-17-propanoic acid
(CHEBI:60778)
verteporfin
(CHEBI:32293)
has part
(2S,21R)-8-ethenyl-21,22-bis(methoxycarbonyl)-13-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,21-dihydrobenzo[b]porphyrin-17-propanoic acid
(CHEBI:60779)
verteporfin
(CHEBI:32293)
has part
(2S,21R)-8-ethenyl-21,22-bis(methoxycarbonyl)-17-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,21-dihydrobenzo[b]porphyrin-13-propanoic acid
(CHEBI:60776)
verteporfin
(CHEBI:32293)
has role
antineoplastic agent
(CHEBI:35610)
verteporfin
(CHEBI:32293)
has role
autophagy inhibitor
(CHEBI:88230)
verteporfin
(CHEBI:32293)
has role
photosensitizing agent
(CHEBI:47868)
verteporfin
(CHEBI:32293)
is a
mixture
(CHEBI:60004)
|
|
trans- (±)- 18- ethenyl- 4,4a- dihydro- 3,4- bis(methoxycarbonyl)- 4a,8,14,19- tetramethyl- 23H,25H- benzo[b]porphine- 9,13- dipropanoic acid monomethyl ester
|
ChEBI
|
trans- (±)- 18- ethenyl- 4,4a- dihydro- 3,4- bis(methoxycarbonyl)- 4a,8,14,19- tetramethyl- 23H,25H- benzo[b]porphine- 9,13- dipropionic acid monomethyl ester
|
ChEBI
|
trans- 18- ethenyl- 4,4a- dihydro- 3,4- bis(methoxycarbonyl)- 4a,8,14,19- tetramethyl- 23H,25H- benzo[b]porphine- 9,13- dipropanoic acid monomethyl ester
|
ChEBI
|
trans- 18- ethenyl- 4,4a- dihydro- 3,4- bis(methoxycarbonyl)- 4a,8,14,19- tetramethyl- 23H,25H- benzo[b]porphine- 9,13- dipropionic acid monomethyl ester
|
ChEBI
|
129497-78-5
|
CAS Registry Number
|
KEGG DRUG
|
129497-78-5
|
CAS Registry Number
|
ChemIDplus
|
13501128
|
Reaxys Registry Number
|
Reaxys
|
13501141
|
Reaxys Registry Number
|
Reaxys
|
25494214
|
PubMed citation
|
Europe PMC
|
26361148
|
PubMed citation
|
Europe PMC
|
26443705
|
PubMed citation
|
Europe PMC
|
|